ARTICLE | Clinical News
Eleven Biotherapeutics preclinical data
May 14, 2012 7:00 AM UTC
In a mouse model of dry eye disease, EBI-005 significantly reduced disease signs as measured by corneal fluorescence staining by 41% at day 11 vs. both cyclosporine and placebo (p<0.0005 for both). Da...